MASTERGRAFT® Granules 7600115Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00721902184987), received between May 18, 2026 and May 18, 2026 — classified as 1 injury.

The most frequently reported specific device problem is “Osseointegration Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryMay 18, 2026Osseointegration Problem

  INFORMATION WAS RECEIVED FROM MULTIPLE SOURCES (HEALTHCARE PROVIDER, CLINICAL STUDY) REGARDING A PATIENT HAVING POSTERIOR CERVICAL L AMINECTOMY. IT WAS REPORTED THAT IMPLANTS WERE USED DURING AN INDEX POSTERIOR SPINAL FIXATION AND FUSION FROM SKULL TO C7. AN ADDITIONAL SPINAL REVISION SURGERY WAS PERFORMED BECAUSE OF FUSION FAILURE. NO ASSESSMENT OF PRODUCT, THERAPY, OR PROCEDURE RELATEDNESS WAS MADE BY THE INVESTIGATOR, SPONSOR, OR CEC. ADDITIONAL INFORMATION WAS RECEIVED THAT THERE WAS NO ASSOCIATED MALFUNCTION REPORTED.

  Patient problems: Inadequate Osseointegration

  MAUDE report 25197417 ↗